$1.25M Accentia Shareholder Settlement Wins Green Light
By Jessica Corso ( February 4, 2015, 5:54 PM EST) -- A Florida federal judge signed off Wednesday on a $1.25 million settlement that ends a class action brought by stockholders of Accentia Biopharmaceuticals Inc. and a subsidiary accusing the companies of lying to investors about the performance of a non-Hodgkin's lymphoma treatment vaccine in development....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.